Delivery Order SPE2DB20D3103-SPE2DB24FN6Y2
- Not listed
- This federal contract award is for the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen, 0.5 ml, with a ceiling value of $3,748.35 and a performance period ending on July 1, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This is a delivery order contract with a firm-fixed-price pricing type. The contract does not have a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen. The contract has a ceiling value of $23,215.87 and an ultimate completion date of December 6, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm fixed-price arrangement and was awarded without any set-aside designations, indicating open...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen, 0.5 ml. The contract, valued at $9,038.75, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price, and the ultimate completion date is July 14, 2025. It is not designated as a set-aside contract, indicating open...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The award, valued at $1,052.00, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of December 14, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of the drug Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,574.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 18, 2023. This contract does not have a set-aside designation, indicating it...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro (15 mg/0.5 ml pen) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $15,365.78 and a completion date of May 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order, with a firm fixed price pricing type. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to support federal healthcare programs. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 1, 2024, with a ceiling value of $1,714.88 and an ultimate completion date of April 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 10 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $20,577.11 and is a firm fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This contract is not set aside for any specific business type. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $1,578. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 28, 2024. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- The federal contract award is for the delivery of Mounjaro 7.5 mg/0.5 ml pen medication, valued at $1,993.76, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN6Y2Delivery Order
This federal contract award is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,453.66 and an ultimate completion date of May 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. This appears to be a delivery order under a broader Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp has a significant role in supplying medical products, including pharmaceuticals, to various federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 5/6/24 |